Recombinant Human Erythropoietin Injection (rhEPO) rhEpo is indicated in the treatment of anemia caused by renal insufficiency, including patients on dialysis and non-dialysis. specification: 1500IU, 2000IU, 3000IU, 4000IU, 6000IU or 10000IU
Delivery terms and packaging
Packaging Detail: 10vials/box, 1PFS/box Delivery Detail: within 30days
By clicking on the "Send" button, you agree that your data will be used to process your request. Further information and revocation instructions can be found in the data protection declaration.